Insider Transactions

Salesforce, Inc. (CRM) Insider Transactions

Over the last 12 months, 18 Salesforce, Inc. (CRM) insiders filed 961 SEC Form 4 transactions — $27.4M in open-market purchases ( 3 distinct buyers) and $82.7M in open-market sales. 0% of all transactions were executed under a pre-scheduled Rule 10b5-1 trading plan.

Recent Form 4 Filings Most recent 50 of 961 (1-year window)

Each row is a single Form 4 filing event for CRM, sourced directly from SEC EDGAR. The Type column classifies the SEC transaction code into Buy / Sell / Grant / Exercise / Other; the 10b5-1 badge marks trades executed under a pre-scheduled SEC Rule 10b5-1 plan.

Date Insider Title Type SEC Code Value Shares Price
2026-05-22 ALBER LAURA Exercise M $0 442 $0.00
2026-05-22 ALBER LAURA Exercise M $0 442 $0.00
2026-05-22 Chang Amy Exercise M $0 442 $0.00
2026-05-22 Chang Amy Exercise M $0 442 $0.00
2026-05-22 Conway Craig Exercise M $0 442 $0.00
2026-05-22 Conway Craig Exercise M $0 442 $0.00
2026-05-22 DONALD ARNOLD W Exercise M $0 442 $0.00
2026-05-22 DONALD ARNOLD W Exercise M $0 442 $0.00
2026-05-22 Kirk David Blair Exercise M $0 442 $0.00
2026-05-22 Kirk David Blair Exercise M $0 442 $0.00
2026-05-22 SACHIN J. MEHRA Exercise M $0 442 $0.00
2026-05-22 SACHIN J. MEHRA Exercise M $0 442 $0.00
2026-05-22 MUNOZ OSCAR Exercise M $0 442 $0.00
2026-05-22 MUNOZ OSCAR Exercise M $0 442 $0.00
2026-05-22 WEBB MAYNARD G JR Exercise M $0 442 $0.00
2026-05-22 WEBB MAYNARD G JR Exercise M $0 442 $0.00
2026-05-22 Roos John Victor Exercise M $0 442 $0.00
2026-05-22 Roos John Victor Exercise M $0 442 $0.00
2026-05-22 Milano Miguel President and CRO Exercise M $0 1,663 $0.00
2026-05-22 Milano Miguel President and CRO Exercise M $0 1,663 $0.00
2026-05-22 KROES NEELIE Exercise M $0 442 $0.00
2026-05-22 KROES NEELIE Exercise M $0 442 $0.00
2026-05-22 Niles Sabastian President and CLO Exercise M $0 1,663 $0.00
2026-05-22 Niles Sabastian President and CLO Exercise M $0 1,663 $0.00
2026-05-22 Milano Miguel President and CRO Other F $122.4K 680 $180.07
2026-05-22 KROES NEELIE Other F $12.1K 67 $180.07
2026-05-22 Niles Sabastian President and CLO Other F $165.7K 920 $180.07
2026-04-22 Tallapragada Srinivas Chief Eng/Cust Success Officer Exercise M $0 1,785 $0.00
2026-04-22 Tallapragada Srinivas Chief Eng/Cust Success Officer Exercise M $0 1,785 $0.00
2026-04-22 Harris Parker Co-Founder and CTO, Slack Exercise M $0 1,785 $0.00
2026-04-22 Harris Parker Co-Founder and CTO, Slack Exercise M $0 1,785 $0.00
2026-04-22 Tallapragada Srinivas Chief Eng/Cust Success Officer Other F $168.2K 886 $189.80
2026-04-22 Tallapragada Srinivas Chief Eng/Cust Success Officer Other F $2.6M 13,781 $189.80
2026-04-22 Harris Parker Co-Founder and CTO, Slack Other F $168.2K 886 $189.80
2026-04-22 Harris Parker Co-Founder and CTO, Slack Other F $2.6M 13,781 $189.80
2026-04-22 Benioff Marc Chair and CEO Other F $4.3M 22,560 $189.80
2026-03-22 Washington Robin L President and COFO Grant $0 7,323 $0.00
2026-03-22 Washington Robin L President and COFO Grant $559.6K 2,864 $195.38
2026-03-22 Washington Robin L President and COFO Grant $0 7,323 $0.00
2026-03-22 Washington Robin L President and COFO Grant $0 58,352 $0.00
2026-03-22 Washington Robin L President and COFO Grant $0 47,059 $0.00
2026-03-22 Milano Miguel President and CRO Grant $0 1,015 $0.00
2026-03-22 Milano Miguel President and CRO Grant $48.5K 248 $195.38
2026-03-22 Milano Miguel President and CRO Grant $0 6,103 $0.00
2026-03-22 Milano Miguel President and CRO Grant $398.6K 2,040 $195.38
2026-03-22 Milano Miguel President and CRO Grant $0 16,084 $0.00
2026-03-22 Milano Miguel President and CRO Grant $0 1,015 $0.00
2026-03-22 Milano Miguel President and CRO Grant $0 6,103 $0.00
2026-03-22 Milano Miguel President and CRO Grant $0 48,626 $0.00
2026-03-22 Milano Miguel President and CRO Grant $0 47,059 $0.00

Showing the most recent 50 of 961 transactions. For the full 1-year history with sorting, filtering, and cross-ticker industry context, open the full insider transactions drilldown.

Top Insider Buyers of CRM By dollar volume, 1-year window

  1. Morfit G Mason $25.0M
  2. Kirk David Blair $1.9M
  3. ALBER LAURA $500.3K

Methodology & FAQ

How We Track CRM Insider Transactions

Form 4 disclosures are sourced directly from SEC EDGAR and re-ingested on every pipeline cycle. A complete description of transaction-code handling, the open-market vs grant distinction, and the Rule 10b5-1 plan-reference heuristic is documented in the Methodology.

What is an SEC Form 4 filing for Salesforce, Inc.?

Form 4 is a transaction-level disclosure that corporate insiders — officers, directors, and beneficial owners of more than 10% of a registered class of equity securities — must file with the SEC within two business days of any change in their beneficial ownership of Salesforce, Inc. (CRM) shares.

What is a Rule 10b5-1 trading plan?

Rule 10b5-1 is an SEC rule that lets insiders schedule trades in advance under a written plan, providing an affirmative defense against insider-trading allegations as long as the plan was adopted in good faith and not while in possession of material non-public information. Form 4 rows marked "10b5-1" on this page indicate the underlying trade was executed under such a plan; rows without the badge are discretionary or did not reference a plan in the Form 4 footnotes.

How is "insider buying" different from a stock grant or option exercise?

An insider buy (SEC transaction code P) is an open-market purchase of Salesforce, Inc. (CRM) stock executed at the prevailing market price using the insider's personal capital. Stock grants (code A) and option exercises (code M) are compensation events, not directional trades; they are tracked separately and excluded from the "conviction" signal because they are not discretionary purchases.

How recent is the data?

Form 4 transactions are typically reported within two business days of execution. Pactolio re-ingests the EDGAR feed on a nightly cycle and reflects new filings on the next ingest run, typically within 24 hours of EDGAR acceptance. The table on this page covers the most recent 1-year window.